Shaboid
Well-Known Member
- Joined
- Apr 30, 2014
- Messages
- 10,319
- Likes
- 13,685
- Points
- 113
In breakthrough, OHSU corrects defective gene that causes deadly disease
http://www.oregonlive.com/health/index.ssf/2017/08/ohsu_genetic_research_that_cou.html#incart_std
A lot of ethical, religious, social, and scientific aspects to this. Would you be okay with OHSU running a clinical trial right in our back yard?
http://www.oregonlive.com/health/index.ssf/2017/08/ohsu_genetic_research_that_cou.html#incart_std
A scientific breakthrough in Oregon that offers hope to those with genetic defects that cause deadly diseases faces steep hurdles to be tested.
Congress has enacted barriers to clinical trials for such genetic trials, and the National Institutes of Health has banned funding.
Even scientists have reservations.
But that doesn't discourage lead researcher Shoukhrat Mitalipov, head of OHSU's center for Embryonic Cell and Gene Therapy. He hopes his success in the laboratory will help soothe fears about genetic manipulation of human embryos.
His team corrected a faulty gene that causes a heart condition that is the most common cause of sudden death in young athletes. The same technique could be used against genes that cause thousands of diseases, including some breast and ovarian cancers.
Two research candidates, Mitalipov said, are two breast cancer gene mutations that have prompted many women, including actress Angelina Jolie, to undergo mastectomies to prevent breast and ovarian cancer.
In theory, the genes could be corrected, preventing generations of women from developing cancer caused by those mutations. But Mitalipov's technique would have to be tested in a clinical trial that is banned in the United States.
A lot of ethical, religious, social, and scientific aspects to this. Would you be okay with OHSU running a clinical trial right in our back yard?

